The Source for Whistleblowers, Journalists, Legislators & Academics

Par Pharmaceutical Engaged in Illegal Drug-Switching Scheme, U.S. Says—9/6/11

In a whistleblower lawsuit, the U.S. alleges that a leading company in drug making and distribution defrauded government healthcare systems by engaging in a nationwide illegal drug-switching scheme. The whistleblower lawsuit became public this week in a Chicago federal court. Twenty states and the District of Columbia have joined the lawsuit filed under the False Claims Act.

Read more at: http://www.bloomberg.com/news/print/2011-09-06/mylan-units-implicated-in-u-s-lawuit-against-par-alleging-drug-switching.html

Related posts

Democracy Misconceived

By William Nettles and Reuben Guttman There is a misconception among many that democracy...

The Art of Advocacy

Judges are now insisting that plaintiffs make their case with facts instead of merely...

Rapamune In the News

The Justice Department on Tuesday joined a whistleblower lawsuit against Pfizer and its subsidiary...

Comments are currently closed.

Top